{"title":"Prospective Evaluation of the Safety and Compression Performance of Novel Compression Denim Jeans in Healthy Volunteers and Patients With Lymphedema.","authors":"Daiki Ousaka, Kiyoshi Yamada, Noriko Sakano, Satoe Kirino, Kazumasa Miyake, Takumi Takahashi, Akihiro Matsuoka, Shintaro Yamada, Akira Shinaoka, Susumu Oozawa","doi":"10.7759/cureus.80971","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The treatment of lower-extremity lymphedema, whether congenital or acquired, remains challenging. Long-term management aimed at reducing complications and maximizing quality of life is essential. Compression stockings are crucial in this management; however, their application is limited by patient experience (ease of wear, texture, breathability, and appearance). This highlights the need to evaluate alternative compression garments that maintain therapeutic efficacy while improving patient adherence.</p><p><strong>Methods: </strong>We developed a novel compression denim product (Flow plus Jeans®) using advanced sewing technology. Its baseline performance (compression ability) was evaluated by measuring pressure gradients at three points (ankle, calf, and thigh) using a mannequin-based compression testing system and compared with those of existing stockings. Thereafter, a safety assessment was conducted on healthy volunteers to evaluate potential adverse effects, including changes in lower limb circumference, signs of deep vein thrombosis (DVT) via ultrasound, and skin complications. A clinical trial in patients with lymphedema was then performed to compare its efficacy with that of conventional compression stockings.</p><p><strong>Results: </strong>Baseline performance testing with a mannequin revealed that Flow plus Jeans demonstrated compression levels and pressure gradients at three calf points comparable to those of standard compression stockings. A safety study involving nine healthy volunteers confirmed that Flow plus Jeans caused no significant changes in lower-limb circumferences after three days of wear, with no cases of DVT or skin complications. In a subsequent clinical trial involving nine female patients with lymphedema, the jeans showed non-inferiority to existing stockings concerning lower-limb circumference measurements at six points (pre-use vs. six months post-use), with patient-reported experiences assessed via questionnaires. Notably, patients reported enhanced satisfaction regarding the jeans' fashionability, which could serve as an incentive for long-term adherence.</p><p><strong>Conclusion: </strong>Our findings suggest that Flow plus Jeans represent a promising novel option for the long-term management of lymphedema, offering an alternative that balances medical efficiency with improved patient satisfaction and demonstrates safety in healthy individuals.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 3","pages":"e80971"},"PeriodicalIF":1.0000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11930548/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cureus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7759/cureus.80971","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The treatment of lower-extremity lymphedema, whether congenital or acquired, remains challenging. Long-term management aimed at reducing complications and maximizing quality of life is essential. Compression stockings are crucial in this management; however, their application is limited by patient experience (ease of wear, texture, breathability, and appearance). This highlights the need to evaluate alternative compression garments that maintain therapeutic efficacy while improving patient adherence.
Methods: We developed a novel compression denim product (Flow plus Jeans®) using advanced sewing technology. Its baseline performance (compression ability) was evaluated by measuring pressure gradients at three points (ankle, calf, and thigh) using a mannequin-based compression testing system and compared with those of existing stockings. Thereafter, a safety assessment was conducted on healthy volunteers to evaluate potential adverse effects, including changes in lower limb circumference, signs of deep vein thrombosis (DVT) via ultrasound, and skin complications. A clinical trial in patients with lymphedema was then performed to compare its efficacy with that of conventional compression stockings.
Results: Baseline performance testing with a mannequin revealed that Flow plus Jeans demonstrated compression levels and pressure gradients at three calf points comparable to those of standard compression stockings. A safety study involving nine healthy volunteers confirmed that Flow plus Jeans caused no significant changes in lower-limb circumferences after three days of wear, with no cases of DVT or skin complications. In a subsequent clinical trial involving nine female patients with lymphedema, the jeans showed non-inferiority to existing stockings concerning lower-limb circumference measurements at six points (pre-use vs. six months post-use), with patient-reported experiences assessed via questionnaires. Notably, patients reported enhanced satisfaction regarding the jeans' fashionability, which could serve as an incentive for long-term adherence.
Conclusion: Our findings suggest that Flow plus Jeans represent a promising novel option for the long-term management of lymphedema, offering an alternative that balances medical efficiency with improved patient satisfaction and demonstrates safety in healthy individuals.
目的:下肢淋巴水肿的治疗,无论是先天性的还是后天的,仍然具有挑战性。旨在减少并发症和提高生活质量的长期管理是必不可少的。压缩袜在这种管理中是至关重要的;然而,它们的应用受到患者体验的限制(易于穿戴、质地、透气性和外观)。这突出了评估替代压缩服装的必要性,以保持治疗效果,同时提高患者的依从性。方法:我们采用先进的缝纫技术开发了一种新颖的压缩牛仔产品(Flow plus Jeans®)。使用人体模型压缩测试系统,通过测量三点(脚踝、小腿和大腿)的压力梯度来评估其基线性能(压缩能力),并与现有丝袜进行比较。之后,对健康志愿者进行安全性评估,以评估潜在的不良反应,包括下肢围度的变化、超声深静脉血栓(DVT)的迹象和皮肤并发症。一项针对淋巴水肿患者的临床试验随后进行,以比较其与传统压缩袜的疗效。结果:与人体模型进行的基线性能测试显示,Flow plus Jeans在三个小腿点表现出与标准压缩袜相当的压缩水平和压力梯度。一项涉及9名健康志愿者的安全性研究证实,Flow plus Jeans在穿了3天后没有引起下肢周长的显著变化,也没有出现深静脉血栓或皮肤并发症。在随后的一项涉及9名女性淋巴水肿患者的临床试验中,牛仔裤在6个点(使用前与使用后6个月)的下肢围度测量显示,与现有丝袜相比,牛仔裤没有劣势,并通过问卷调查评估了患者报告的体验。值得注意的是,患者报告说,他们对牛仔裤的时尚感更满意,这可能会激励他们长期坚持。结论:我们的研究结果表明,Flow + Jeans为淋巴水肿的长期治疗提供了一个有希望的新选择,提供了一种平衡医疗效率和提高患者满意度的替代方案,并证明了健康个体的安全性。